학술논문
Understanding the impact of risankizumab on keratinocyte-derived IL-23A in a novel organotypic 3D skin model containing IL-23A responsive and IL-17A producing γδ-T-cells.
Document Type
Article
Author
Source
Cutaneous & Ocular Toxicology; Jun2024, Vol. 43 Issue 2, p124-128, 5p
Subject
Language
ISSN
15569527
Abstract
Copyright of Cutaneous & Ocular Toxicology is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)